SUSANNAH GRAY - 02 May 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: Director
Signature: /s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol: TBPH
Transactions as of: 02 May 2023
Net transactions value: $0
Form type: 4
Filing time: 04 May 2023, 18:38:05 UTC
Previous filing: 28 Feb 2023
Next filing: 25 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBPH	Ordinary Shares	Award	$0	+9,132	+77%	$0.000000	20,951	02 May 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBPH	Share Option (Right to Buy)	Award	$0	+22,044		$0.000000	22,044	02 May 2023	Ordinary Shares	22,044	$10.95	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.